Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, The Clorox Company (CLX) has a Wall Street consensus price target of $121.00, based on estimates from 28 covering analysts. With the stock currently trading at $127.16, this represents a potential downside of -4.8%. The company has a market capitalization of $16.63B.
Analyst price targets range from a low of $94.00 to a high of $152.00, representing a 48% spread in expectations. The median target of $121.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,20 rating it Hold, and 4 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CLX trades at a trailing P/E of 19.5x and forward P/E of 21.5x. Analysts expect EPS to grow -4.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $118.92, with bear and bull scenarios of $45.39 and $113.10 respectively. Model confidence stands at 62/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CLX stacks up against sector leader Walmart Inc..
Start ComparisonWall Street's consensus price target for CLX is $121, -4.8% from its current price of $127.16. The below-market target from 28 analysts suggests limited near-term appreciation.
CLX has a consensus rating of "Hold" based on 28 Wall Street analysts. The rating breakdown is mixed, with 20 Hold ratings making up the largest segment. The consensus 12-month price target of $121 implies -4.8% downside from current levels.
CLX trades at a forward P/E of 21.5084x, representing a moderate valuation. With analysts targeting $121 (-4.8% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $152 for CLX, while the most conservative target is $94. The consensus of $121 represents the median expectation. Our quantitative valuation model projects a bull case target of $113 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CLX is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 20 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLX stock forecast based on 28 Wall Street analysts shows a consensus price target of $121, with estimates ranging from $94 (bear case) to $152 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $119, with bear/bull scenarios of $45/$113.
Our quantitative valuation model calculates CLX's fair value at $119 (base case), with a bear case of $45 and bull case of $113. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.
CLX trades at a forward P/E ratio of 21.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 19.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CLX, with 4 Sell ratings and a price target of $121 (-4.8% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLX analyst price targets range from $94 to $152, a 48% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $121 consensus represents the middle ground. Our model's $45-$113 range provides an independent fundamental perspective.